Top U.S. General Says It Would Be Difficult This Year For Ukraine To Remove All Russian Forces From Occupied Territories; This War Will End On The Negotiation Table But Timing Up To Parties Involved

– Reuters

byBenzinga Newsdesk

January 20, 2023

1 minute read

– Reuters

Why Penn National Gaming’s Stock Is Trading Higher Today

By Randy Elias

Today, 8:47 AM

Penn National Gaming, Inc. (NASDAQ: PENN) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and announced it will acquire Score Media And Gaming for $17 per share in cash.

PENN

Evercore ISI Group Maintains In-Line on AvalonBay Communities, Lowers Price Target to $220

By Benzinga Newsdesk

Today, 8:47 AM

Evercore ISI Group analyst Steve Sakwa maintains AvalonBay Communities (NYSE:AVB) with a In-Line and lowers the price target from $230 to $220.

AVB

Where Could DatChat Be Headed?

By Tyler Bundy

Today, 8:47 AM

DatChat Inc (NASDAQ: DATS) shares are trading higher Thursday after the company announced the launch of DatChat Social Network+, a social network focused on expanding the DatChat platform. DatChat was up 6.32% at $8 at last check Thursday.

DATS

FDA
News

Seagen Says FDA Grants Regular Approval, Expands Indication For PADCEV For Patients With Locally Advanced Or Metastatic Urothelial Cancer

By Benzinga Newsdesk

Today, 8:47 AM

Seagen Inc. (NASDAQ:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the U.S. Food and Drug Administration (FDA) granted

SGEN

Top U.S. General Says It Would Be Difficult This Year For Ukraine To Remove All Russian Forces From Occupied Territories; This War Will End On The Negotiation Table But Timing Up To Parties Involved

Related Posts

Why Penn National Gaming’s Stock Is Trading Higher Today

Evercore ISI Group Maintains In-Line on AvalonBay Communities, Lowers Price Target to $220

Where Could DatChat Be Headed?

Seagen Says FDA Grants Regular Approval, Expands Indication For PADCEV For Patients With Locally Advanced Or Metastatic Urothelial Cancer